Table 1. Patient demographics.
| Demographics | N=51 |
|---|---|
| Mean age [range] in years | 54.5 [27–67] |
| Race | |
| Caucasian | 49 (96%) |
| African-American | 2 (4%) |
| Asian | 0 (0%) |
| Other | 0 (0%) |
| Relationship status | |
| In a relationship | 40 (78%) |
| Single | 11 (22%) |
| Comorbidities | |
| Diabetes mellitus | 10 (19%) |
| Hypertension | 27 (53%) |
| CAD/PVD | 4 (7%) |
| Duration of Peyronie’s disease (mean, range) in months | 25.5 [1–120] |
| Pain | |
| No | 28 (55%) |
| Yes | 23 (45%) |
| Previous treatment for Peyronie’s disease | |
| No | 29 (57%) |
| Oral | 17 (33%) |
| Injectable | 5 (10%) |
| History of trauma | |
| No | 33 (65%) |
| Yes | 18 (35%) |
| Treatment for erectile dysfunction | |
| No | 22 (43%) |
| PDE-5 Inhibitors | 27 (53%) |
| VED | 2 (4%) |
| Direction of curvature | |
| Dorsal | 27 (53%) |
| Dorsal-lateral | 13 (25%) |
| Lateral | 11 (22%) |
| Degree of curvature | |
| 30˚–60˚ | 26 (51%) |
| >60˚ | 25 (49%) |
| Vascular findings | |
| Venous leak | 30 (59%) |
| Arterial insufficiency | 1 (2%) |
| Mixed vascular | 6 (12%) |
| Non-vascular | 14 (27%) |
| Mean follow-up [range] in months | 9.4 [3–26] |
CAD, coronary artery disease; PVD, peripheral vascular disease; VED, vacuum erection device.